Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies.
Bone mineral density (BMD) was measured in 23 patients who had undergone bone marrow transplantation (BMT) at the University of Minnesota for myeloid leukemia. The median age at BMT was 22 years (range 3-53) and the median age at assessment of BMD was 27 years (range 4-56). Total body BMD was measured a median of 2 years (range 1-10) after BMT using Dual Photon X-ray Absorptiometry (DEXA). BMD was measured in g/cm2, with results expressed as percent of normal values and as Z (standard deviation) scores. Patients were categorized into two groups (pediatric and adult) according to age at BMT (< or = 18 years vs > 18 years). Total body BMD of patients in the pediatric age group was significantly decreased (median Z-score -0.5) compared to the adult population (median Z-score 0.0, P = 0.03). No association was observed between BMD and time elapsed since BMT, type of conditioning regimen, gonadal function, steroid intake or graft-versus-host disease. Investigation of decreased BMD in children with AML following BMT is needed to determine the metabolic basis, long-term implications, appropriate preventive measures and potential interventions.
Bhatia
S
S
Division of Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, USA.
Ramsay
N K
NK
Weisdorf
D
D
Griffiths
H
H
Robison
L L
LL
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D015519:Bone Density; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged